H-D-Phe(4-NO2)-OHCAS# 56613-61-7 |
- Hydroxyfasudil
Catalog No.:BCC1635
CAS No.:105628-72-6
- chroman 1
Catalog No.:BCC1480
CAS No.:1273579-40-0
- Y-27632 dihydrochloride
Catalog No.:BCC1273
CAS No.:129830-38-2
- Hydroxyfasudil hydrochloride
Catalog No.:BCC1636
CAS No.:155558-32-0
- H-1152 dihydrochloride
Catalog No.:BCC1616
CAS No.:871543-07-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 56613-61-7 | SDF | Download SDF |
| PubChem ID | 679497 | Appearance | Powder |
| Formula | C9H10N2O4 | M.Wt | 210.2 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | C1=CC(=CC=C1CC(C(=O)O)N)[N+](=O)[O-] | ||
| Standard InChIKey | GTVVZTAFGPQSPC-MRVPVSSYSA-N | ||
| Standard InChI | InChI=1S/C9H10N2O4/c10-8(9(12)13)5-6-1-3-7(4-2-6)11(14)15/h1-4,8H,5,10H2,(H,12,13)/t8-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
H-D-Phe(4-NO2)-OH Dilution Calculator
H-D-Phe(4-NO2)-OH Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.7574 mL | 23.7869 mL | 47.5737 mL | 95.1475 mL | 118.9343 mL |
| 5 mM | 0.9515 mL | 4.7574 mL | 9.5147 mL | 19.0295 mL | 23.7869 mL |
| 10 mM | 0.4757 mL | 2.3787 mL | 4.7574 mL | 9.5147 mL | 11.8934 mL |
| 50 mM | 0.0951 mL | 0.4757 mL | 0.9515 mL | 1.9029 mL | 2.3787 mL |
| 100 mM | 0.0476 mL | 0.2379 mL | 0.4757 mL | 0.9515 mL | 1.1893 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
H-D-Phe(4-NO2)-OH
- BOP reagent
Catalog No.:BCC2807
CAS No.:56602-33-6
- Formestane
Catalog No.:BCC4369
CAS No.:566-48-3
- 7Beta-Hydroxycholesterol
Catalog No.:BCN2751
CAS No.:566-27-8
- 7-Keto-dehydroepiandrosterone
Catalog No.:BCC8780
CAS No.:566-19-8
- 3-Hydroxy-2-phenyl-propanamide
Catalog No.:BCN3905
CAS No.:56598-62-0
- PIT
Catalog No.:BCC7151
CAS No.:56583-49-4
- (-)-Bornyl acetate
Catalog No.:BCN2636
CAS No.:5655-61-8
- Cyclo(Pro-Val)
Catalog No.:BCN2420
CAS No.:5654-87-5
- Cyclo(Pro-Leu)
Catalog No.:BCN2426
CAS No.:5654-86-4
- Cyclo(Tyr-Pro)
Catalog No.:BCN2421
CAS No.:5654-84-2
- 2-Hydroxy-3,4-dimethoxybenzoic acid
Catalog No.:BCN6535
CAS No.:5653-46-3
- Angelic acid
Catalog No.:BCN3410
CAS No.:565-63-9
- D-Phenylglycinol
Catalog No.:BCC2712
CAS No.:56613-80-0
- Z-Arg-OH.HCl
Catalog No.:BCC3061
CAS No.:56672-63-0
- Batatasin III
Catalog No.:BCN3596
CAS No.:56684-87-8
- 2-Benzylacrylic acid
Catalog No.:BCC8564
CAS No.:5669-19-2
- Orteronel
Catalog No.:BCC1823
CAS No.:566939-85-3
- (+/-)-Vestitol
Catalog No.:BCN6814
CAS No.:56701-24-7
- Z-Glu-OMe
Catalog No.:BCC2779
CAS No.:5672-83-3
- Icariside I
Catalog No.:BCN3463
CAS No.:56725-99-6
- 1-Methoxyallocryptopine
Catalog No.:BCN7454
CAS No.:56743-52-3
- Phenylalanine betaine
Catalog No.:BCN5761
CAS No.:56755-22-7
- Etifoxine hydrochloride
Catalog No.:BCC1561
CAS No.:56776-32-0
- Scopoletin acetate
Catalog No.:BCN5762
CAS No.:56795-51-8
Plant peptide hormone phytosulfokine (PSK-alpha): synthesis of new analogues and their biological evaluation.[Pubmed:15298181]
J Pept Sci. 2004 Jul;10(7):462-9.
Phytosulfokine-alpha (PSK-alpha), a sulfated growth factor (H-Tyr(SO3H)-Ile-Tyr(SO3H)-Thr-Gln-OH) universally found in both monocotyledons and dicotyledons, strongly promotes proliferation of plant cells in culture. In our studies on structure/activity relationship in PSK-alpha the synthesis of a series of analogues was performed: [H-D-Tyr(SO3H)1]- (9), [H-Phe(4-SO3H)1]- (10), [H-D-Phe(4-SO3H)1]- (11), [H-Phg(4-SO3H)1]- (12), [H-D-Phg(4-SO3H)1]- (13), H-Phe(4-NHSO2CH3)1]- (14), [H-D-Phe(4-NHSO2CH3)1]- (15), [H-Phe(4-NO2)1]- (16), [H-D-Phe(4-NO2)1]- (17), [H-Phg(4-NO2)1]- (18), [H-D-Phg(4-NO2)1]- (19), [H-Hph(4-NO2)1]- (20), [H-Phg(4-OSO3H)1]- (21), [Phe(4-NO2)3]- (22), [Phg(4-NO2)3]- (23), [Hph(4-NO2)3]- (24), [H-Phe(4-SO3H)1, Phe(4-SO3H)3]- (25) [H-Phe(4-NO2)1, Phe(4-NO2)3]- (26), [H-Phg(4-NO2)1, Phg(4-NO2)3]- (27), [H-Hph(4-NO2)1, Hph(4-NO2)3]- (28) and [Val3]- PSK-alpha (29). For modification of the PSK-alpha peptide chain the novel amino acids and their derivatives were synthesized, such as: H-L-Phg(4-SO3H)-OH (1), H-D-Phg(4-SO3H)-OH (2), Fmoc-Phg(4-SO3H)-OH (3), Fmoc-D-Phg(4-SO3H)-OH (4), Boc-Phg(4-NHSO2CH3)-OH (5), Boc-D-Phg(4-NHSO2CH3)-OH (6) Boc-Phe(4-NHSO2CH3)-OH (7), and Boc-D-Phe(4-NHSO2CH3)-OH (8). Peptides were synthesized by a solid phase method according to the Fmoc procedure on a Wang-resin. Free peptides were released from the resin by 95% TFA in the presence of EDT. All peptides were tested by competitive binding assay to the carrot membrane using 3H-labelled PSK according to the Matsubayashi et al. test.
